“PRIMARYS” study Investigators observed clinically relevant results in an investigational Phase III study with Somatuline® Autogel® 120 mg in patients with acromegaly

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023